Post-earnings recap
Reported
Wed, May 2, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
63%
Dexcom's earnings report shows a miss on EPS, which reflects ongoing challenges the company faces. Despite this, the stock rose by 1.25%, likely due to investor optimism about future growth and innovation efforts. The lack of revenue data and guidance may leave some investors cautious about the company's near-term outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | -$0.32 | N/A | -6.28% |
| Revenue | N/A | N/A | N/A |
Management expressed caution regarding market conditions and emphasized the need for continued innovation. They did not provide specific guidance for the upcoming quarters.
Management highlighted ongoing challenges in the market.
They emphasized the importance of innovation in their product line.
There was a focus on maintaining operational efficiency.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—